Rtw Investments, LP Sage Therapeutics, Inc. Transaction History
Rtw Investments, LP
- $6.27 Billion
- Q3 2024
A detailed history of Rtw Investments, LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 5,591,700 shares of SAGE stock, worth $30.6 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
5,591,700
Previous 5,480,577
2.03%
Holding current value
$30.6 Million
Previous $59.5 Million
32.26%
% of portfolio
0.64%
Previous 0.99%
Shares
5 transactions
Others Institutions Holding SAGE
# of Institutions
198Shares Held
46.5MCall Options Held
402KPut Options Held
209K-
Vanguard Group Inc Valley Forge, PA5.76MShares$31.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$28.6 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$24.4 Million0.54% of portfolio
-
State Street Corp Boston, MA2.93MShares$16 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.5MShares$8.21 Million0.01% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $326M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...